Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 (2021).
Google Scholar
DeTure, M. A. & Dickson, D. W. The neuropathological diagnosis of Alzheimer’s disease. Mol. Neurodegener. 14, 32 (2019).
Google Scholar
O’Brien, R. J. & Wong, P. C. Amyloid precursor protein processing and Alzheimer’s disease. Annu. Rev. Neurosci. 34, 185–204 (2011).
Google Scholar
Agostinho, P., Cunha, R. A. & Oliveira, C. Neuroinflammation, oxidative stress and the pathogenesis of alzheimers disease. Curr. Pharm. Des. 16, 2766–2778 (2010).
Google Scholar
Brockmann, R., Nixon, J., Love, B. L. & Yunusa, I. Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer’s disease: patient outcomes, healthcare costs, and drug development. Lancet Reg. Health Am. 20, 100467 (2023).
Google Scholar
Haskell-Ramsay, C. F., Schmitt, J. & Actis-Goretta, L. The impact of epicatechin on human cognition: The role of cerebral blood flow. Nutrients 10, 986 (2018).
Google Scholar
Maccioni, R. B., Calfío, C., González, A. & Lüttges, V. Novel nutraceutical compounds in Alzheimer prevention. Biomolecules 12, 249 (2022).
Google Scholar
Baig, M. H., Ahmad, K., Rabbani, G. & Choi, I. Use of peptides for the management of Alzheimer’s disease: Diagnosis and inhibition. Front. Aging Neurosci. 10, 21 (2018).
Google Scholar
Maebuchi, M., Kishi, Y., Koikeda, T. & Furuya, S. Soy peptide dietary supplementation increases serum dopamine level and improves cognitive dysfunction in subjects with mild cognitive impairment. Jpn. Pharmacol. Ther. 41, 67–73 (2013).
Google Scholar
Yuda, N. et al. Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial. Clin. Interv. Aging 15, 743–754 (2020).
Google Scholar
Tanaka, M. et al. Brain-transportable dipeptides across the blood-brain barrier in mice. Sci. Rep. 9, 5769 (2019).
Google Scholar
Cheng, L. et al. A memory-improving dipeptide, Tyr-Pro, can reach the mouse brain after oral administration. Sci. Rep. 13, 16908 (2023).
Google Scholar
Tanaka, M. et al. Brain-transportable soy dipeptide, Tyr-Pro, attenuates amyloid β peptide25-35-induced memory impairment in mice. npj Sci. Food 4, 7 (2020).
Google Scholar
Alonso, A. C., Grundke-Iqbal, I. & Iqbal, K. Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783–787 (1996).
Google Scholar
Iqbal, K., Liu, F. & Gong, C.-X. Tau and neurodegenerative disease: the story so far. Nat. Rev. Neurol. 12, 15–27 (2016).
Google Scholar
Del Valle, J. et al. Early amyloid accumulation in the hippocampus of SAMP8 mice. J. Alzheimers Dis. 19, 1303–1315 (2010).
Google Scholar
Pačesová, A. et al. Age-related metabolic and neurodegenerative changes in SAMP8 mice. Aging (Albany NY) 14, 7300–7327 (2022).
Google Scholar
Gómez-Oliva, R. et al. Rescue of neurogenesis and age-associated cognitive decline in SAMP8 mouse: role of transforming growth factor alpha. Aging Cell. 22, e13829 (2023).
Google Scholar
Canudas, A. M. et al. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM). Mech. Ageing Dev. 126, 1300–1304 (2005).
Google Scholar
Vassar, R. & Citron, M. Abeta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron 27, 419–422 (2000).
Google Scholar
Chen, G.-F. et al. Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol. Sin. 38, 1205–1235 (2017).
Google Scholar
Akiguchi, I. et al. SAMP8 mice as a neuropathological model of accelerated brain aging and dementia: Toshio Takeda’s legacy and future directions. Neuropathology 37, 293–305 (2017).
Google Scholar
Song, C., Zhang, T. & Zhang, Y. Conformational essentials responsible for neurotoxicity of Aβ42 aggregates revealed by antibodies against oligomeric Aβ42. Molecules 27, 6751 (2022).
Google Scholar
Butterfield, D. A. & Poon, H. F. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer’s disease. Exp. Gerontol. 40, 774–783 (2005).
Google Scholar
Wang, F., Chen, H., Sun, X. J. & Ke, Z. J. Improvement of cognitive deficits in SAMP8 mice by 3-n-butylphthalide. Neurol. Res. 36, 224–233 (2014).
Google Scholar
Zhang, Z.-X., Zhao, R.-P., Wang, D.-S. & Li, Y.-B. Fuzhisan ameliorates the memory deficits in aged SAMP8 mice via decreasing Aβ production and tau hyperphosphorylation of the hippocampus. Neurochem. Res. 41, 3074–3082 (2016).
Google Scholar
Lv, L.-L. et al. Dendrobium nobile Lindl. Alkaloids ameliorate cognitive dysfunction in senescence accelerated SAMP8 mice by decreasing amyloid-β aggregation and enhancing autophagy activity. J. Alzheimers Dis. 76, 657–669 (2020).
Google Scholar
Zheng, Y. et al. Fermented soybean foods (natto) ameliorate age-related cognitive decline by hippocampal TAAR1-mediated activation of the CaMKII/CREB/BDNF signaling pathway in senescence-accelerated mouse prone 8 (SAMP8). Food Funct. 14, 10097–10106 (2023).
Google Scholar
Lee, J. K. et al. Neuroprotective Effect of β-secretase Inhibitory Peptide from Pacific Hake (Merluccius productus) Fish Protein Hydrolysate. Curr. Alzheimer Res. 16, 1028–1038 (2019).
Google Scholar
Yu, Z. et al. Identification of ovalbumin-derived peptides as multi-target inhibitors of AChE, BChE, and BACE1. J. Sci. Food Agric. 100, 2648–2655 (2020).
Google Scholar
Bian, L. et al. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese. Neurology 63, 241–245 (2004).
Google Scholar
Corraliza-Gomez, M. et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of Alzheimer’s disease and brain aging. J. Neuroinflam. 20, 233 (2023).
Google Scholar
Shen, Y., Joachimiak, A., Rosner, M. R. & Tang, W.-J. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870–874 (2006).
Google Scholar
Sousa, L., Guarda, M., Meneses, M. J., Macedo, M. P. & Vicente Miranda, H. Insulin-degrading enzyme: an ally against metabolic and neurodegenerative diseases. J. Pathol. 255, 346–361 (2021).
Google Scholar
Takamatsu, Y. et al. Combined immunotherapy with “anti-insulin resistance” therapy as a novel therapeutic strategy against neurodegenerative diseases. npj Parkinsons Dis. 3, 4 (2017).
Google Scholar
Lee, A. Y., Lee, M. H., Lee, S. & Cho, E. J. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation. J. Agric. Food Chem. 65, 10719–10729 (2017).
Google Scholar
Lee, S.-J. et al. Dietary curcumin restores insulin homeostasis in diet-induced obese aged mice. Aging (Albany NY) 14, 225–239 (2022).
Google Scholar
Zhao, L. et al. Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer’s disease intervention. J. Neurosci. 24, 11120–11126 (2004).
Google Scholar
Lee, Y. et al. In vitro and in silico characterization of adiponectin-receptor agonist dipeptides. npj Sci. Food 5, 29 (2021).
Google Scholar
Cheng, L. et al. Adiponectin-receptor agonistic dipeptide Tyr-Pro stimulates the acetylcholine nervous system in NE-4C cells. J. Agric. Food Chem. 72, 7121–7129 (2024).
Google Scholar
Morris, R. G. M. Spatial localization does not require the presence of local cues. Learn. Motiv. 12, 239–260 (1981).
Google Scholar
Kubota, K. et al. The traditional Japanese herbal medicine hachimijiogan elicits neurite outgrowth effects in PC12 cells and improves cognitive in AD model rats via phosphorylation of CREB. Front. Pharmacol. 8, 850 (2017).
Google Scholar